Diabetic sarcopenia. Muscle wasting and atrophy, not elsewhere classified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: At least a history of 6 months of type 2 diabetes confirmed by a specialist doctor Diagnosis of sarcopenia according to the criteria mentioned in the study method Signing a written consent to participate in the study Not using other supplements Absence of severe hepatic or renal disorder Absence of cancer
Exclusion criteria
Exclusion criteria: Existence of musculoskeletal disorders (back pain, knee pain, etc.) that lead to impaired walking The existence of comorbid orthopedic and neurological problems such as stroke, cerebral palsy, poliomyelitis, rheumatoid arthritis, and prosthesis The patient's unwillingness to cooperate Occurrence of any unforeseen problems in patients Not using more than 10% of supplements given in each follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle mass index (muscle mass of 4 organs per height squared). Timepoint: Twice with an interval of 12 weeks. Method of measurement: DEXA (dual x-ray absorptiometry). | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood sugar. Timepoint: Twice with an interval of 12 weeks. Method of measurement: Blood test.;Inflammatory markers. Timepoint: Twice with an interval of 12 weeks. Method of measurement: Blood test.;Lipid profile. Timepoint: Twice with an interval of 12 weeks. Method of measurement: Blood test.;Vitamin D. Timepoint: Twice with an interval of 12 weeks. Method of measurement: Blood test.;Walking speed (the person's usual walking speed). Timepoint: Twice 12 weeks apart. Method of measurement: stopwatch.;Muscle strength (maximum muscle strength of both arms). Timepoint: Twice 12 weeks apart. Method of measurement: Dynamometer device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences